2-Substituted quinoline alkaloids as potential antileishmanial drugs

Abstract. Ten 2-substituted quinoline alkaloids isolated from a plant used for treatment of New World cutaneous leishmaniasis have antileishmanial in vitro activities against the extracellular forms of Leishmania spp. BALB/c mice infected with Leishmania amazonensis PH8 or H-142 or Leishmania venezuelensis were treated 1 day after the parasitic infection with a quinoline alkaloid (100 mg/kg of body weight per day) or with reference drug N-methylglucamine antimonate (Glucantime) (56 mg of pentavalent antimony [Sbv] per kg per day) for 14 days. Lesion development was the criterium used to assess disease severity. Two three-carbon chain quinolines [2-n-propylquinoline and 2-(1',2'-trans-epoxypropyl)quinoline (chimanine D)] were more potent than N-methylglucamine antimonate against L. amazonensis PH8, and five quinoline alkaloids [2-(3,4-methylenedioxyphenylethyl)quinoline, cusparine, 2-(3,4-dimethoxyphenylethyl)quinoline, 2-(E)-prop-1'-enylquinoline (chimanine B), and skimmianine] were as effective as the reference drug. Single treatment near the site of infection, 14 days after infection with L. amazonensis, with 2-n-propylquinoline or chimanine B reduced the severity of lesions but less notably than N-methylglucamine antimonate. 2-n-Propylquinoline exhibited significant activity against the virulent strain L. venezuelensis. The active products did not show any apparent toxicities during the experiment. This study is, to our knowledge, the first to show the activity of 2-substituted quinoline alkaloids for experimental treatment of New World cutaneous leishmaniasis. Further investigations of these compounds might yet prove helpful for the development of new antileishmanial drugs.

Saved in:
Bibliographic Details
Main Authors: Fournet, Alain, Angelo Barrios, Alcira, Muñoz, Victoria, Hocquemiller, Reynald, Cavé, André, Bruneton, Jean
Format: Article biblioteca
Language:English
Published: Antimicrobial Agents and Chemotherapy 1993-04
Subjects:QUINOLINA, ALCALOIDES DE QUINOLINA, DROGAS ANTILEISHMANIAL,
Online Access:http://repositorio.umsa.bo/xmlui/handle/123456789/16695
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:localhost:8080:123456789-16695
record_format koha
spelling oai:localhost:8080:123456789-166952020-08-27T21:06:40Z 2-Substituted quinoline alkaloids as potential antileishmanial drugs Fournet, Alain Angelo Barrios, Alcira Muñoz, Victoria Hocquemiller, Reynald Cavé, André Bruneton, Jean QUINOLINA ALCALOIDES DE QUINOLINA DROGAS ANTILEISHMANIAL Abstract. Ten 2-substituted quinoline alkaloids isolated from a plant used for treatment of New World cutaneous leishmaniasis have antileishmanial in vitro activities against the extracellular forms of Leishmania spp. BALB/c mice infected with Leishmania amazonensis PH8 or H-142 or Leishmania venezuelensis were treated 1 day after the parasitic infection with a quinoline alkaloid (100 mg/kg of body weight per day) or with reference drug N-methylglucamine antimonate (Glucantime) (56 mg of pentavalent antimony [Sbv] per kg per day) for 14 days. Lesion development was the criterium used to assess disease severity. Two three-carbon chain quinolines [2-n-propylquinoline and 2-(1',2'-trans-epoxypropyl)quinoline (chimanine D)] were more potent than N-methylglucamine antimonate against L. amazonensis PH8, and five quinoline alkaloids [2-(3,4-methylenedioxyphenylethyl)quinoline, cusparine, 2-(3,4-dimethoxyphenylethyl)quinoline, 2-(E)-prop-1'-enylquinoline (chimanine B), and skimmianine] were as effective as the reference drug. Single treatment near the site of infection, 14 days after infection with L. amazonensis, with 2-n-propylquinoline or chimanine B reduced the severity of lesions but less notably than N-methylglucamine antimonate. 2-n-Propylquinoline exhibited significant activity against the virulent strain L. venezuelensis. The active products did not show any apparent toxicities during the experiment. This study is, to our knowledge, the first to show the activity of 2-substituted quinoline alkaloids for experimental treatment of New World cutaneous leishmaniasis. Further investigations of these compounds might yet prove helpful for the development of new antileishmanial drugs. 2018-06-19T14:02:44Z 2018-06-19T14:02:44Z 1993-04 Article http://repositorio.umsa.bo/xmlui/handle/123456789/16695 en application/pdf Antimicrobial Agents and Chemotherapy
institution UMSA BO
collection DSpace
country Bolivia
countrycode BO
component Bibliográfico
access En linea
databasecode dig-umsa-bo
tag biblioteca
region America del Sur
libraryname Sistema de Unidades de Información de UMSA
language English
topic QUINOLINA
ALCALOIDES DE QUINOLINA
DROGAS ANTILEISHMANIAL
QUINOLINA
ALCALOIDES DE QUINOLINA
DROGAS ANTILEISHMANIAL
spellingShingle QUINOLINA
ALCALOIDES DE QUINOLINA
DROGAS ANTILEISHMANIAL
QUINOLINA
ALCALOIDES DE QUINOLINA
DROGAS ANTILEISHMANIAL
Fournet, Alain
Angelo Barrios, Alcira
Muñoz, Victoria
Hocquemiller, Reynald
Cavé, André
Bruneton, Jean
2-Substituted quinoline alkaloids as potential antileishmanial drugs
description Abstract. Ten 2-substituted quinoline alkaloids isolated from a plant used for treatment of New World cutaneous leishmaniasis have antileishmanial in vitro activities against the extracellular forms of Leishmania spp. BALB/c mice infected with Leishmania amazonensis PH8 or H-142 or Leishmania venezuelensis were treated 1 day after the parasitic infection with a quinoline alkaloid (100 mg/kg of body weight per day) or with reference drug N-methylglucamine antimonate (Glucantime) (56 mg of pentavalent antimony [Sbv] per kg per day) for 14 days. Lesion development was the criterium used to assess disease severity. Two three-carbon chain quinolines [2-n-propylquinoline and 2-(1',2'-trans-epoxypropyl)quinoline (chimanine D)] were more potent than N-methylglucamine antimonate against L. amazonensis PH8, and five quinoline alkaloids [2-(3,4-methylenedioxyphenylethyl)quinoline, cusparine, 2-(3,4-dimethoxyphenylethyl)quinoline, 2-(E)-prop-1'-enylquinoline (chimanine B), and skimmianine] were as effective as the reference drug. Single treatment near the site of infection, 14 days after infection with L. amazonensis, with 2-n-propylquinoline or chimanine B reduced the severity of lesions but less notably than N-methylglucamine antimonate. 2-n-Propylquinoline exhibited significant activity against the virulent strain L. venezuelensis. The active products did not show any apparent toxicities during the experiment. This study is, to our knowledge, the first to show the activity of 2-substituted quinoline alkaloids for experimental treatment of New World cutaneous leishmaniasis. Further investigations of these compounds might yet prove helpful for the development of new antileishmanial drugs.
format Article
topic_facet QUINOLINA
ALCALOIDES DE QUINOLINA
DROGAS ANTILEISHMANIAL
author Fournet, Alain
Angelo Barrios, Alcira
Muñoz, Victoria
Hocquemiller, Reynald
Cavé, André
Bruneton, Jean
author_facet Fournet, Alain
Angelo Barrios, Alcira
Muñoz, Victoria
Hocquemiller, Reynald
Cavé, André
Bruneton, Jean
author_sort Fournet, Alain
title 2-Substituted quinoline alkaloids as potential antileishmanial drugs
title_short 2-Substituted quinoline alkaloids as potential antileishmanial drugs
title_full 2-Substituted quinoline alkaloids as potential antileishmanial drugs
title_fullStr 2-Substituted quinoline alkaloids as potential antileishmanial drugs
title_full_unstemmed 2-Substituted quinoline alkaloids as potential antileishmanial drugs
title_sort 2-substituted quinoline alkaloids as potential antileishmanial drugs
publisher Antimicrobial Agents and Chemotherapy
publishDate 1993-04
url http://repositorio.umsa.bo/xmlui/handle/123456789/16695
work_keys_str_mv AT fournetalain 2substitutedquinolinealkaloidsaspotentialantileishmanialdrugs
AT angelobarriosalcira 2substitutedquinolinealkaloidsaspotentialantileishmanialdrugs
AT munozvictoria 2substitutedquinolinealkaloidsaspotentialantileishmanialdrugs
AT hocquemillerreynald 2substitutedquinolinealkaloidsaspotentialantileishmanialdrugs
AT caveandre 2substitutedquinolinealkaloidsaspotentialantileishmanialdrugs
AT brunetonjean 2substitutedquinolinealkaloidsaspotentialantileishmanialdrugs
_version_ 1766394546670796800